Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02947321 · ClinicalTrials.gov registry record · NA
Genicular Radiofrequency Ablation Efficacy in Achieving Total Knee Pain Reduction Trial
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02947321 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 60 participants.
The verdict
NCT02947321, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Given the benefits of genicular nerve radiofrequency ablation (RFA) in improving pain and functional status in non-surgical patients with knee osteoarthritis as well as the high prevalence of postoperative pain from total knee arthroplasty (TKA), this study is designed to determine the efficacy of preoperative genicular nerve RFA in improving acute and chronic postoperative pain as well as functional status in patients undergoing TKA. Patients will be randomized to one of two study arms: RFA group (genicular nerve thermal RFA) or control group (RFA needles placed in proper location without effective neurotomy).
Interventions
- PROCEDURE Genicular Nerve RFA
- PROCEDURE Sham Genicular Nerve RFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-01-26 |
| Est. Completion | 2020-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02947321
The ClinicalTrials.gov registry entry for NCT02947321 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Genicular Nerve RFA is the first listed.
NCT02947321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02947321 about?
NCT02947321 is a clinical study titled "Genicular Radiofrequency Ablation Efficacy in Achieving Total Knee Pain Reduction Trial". Given the benefits of genicular nerve radiofrequency ablation (RFA) in improving pain and functional status in non-surgical patients with knee osteoarthritis as well as the high prevalence of postoperative pain from total knee arthroplasty (TKA), this study is designed to determine the efficacy of p...
What is the current status of trial NCT02947321?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-01-26. Estimated completion is 2020-09-09.
What interventions are being tested in trial NCT02947321?
The interventions under investigation include: Genicular Nerve RFA (PROCEDURE), Sham Genicular Nerve RFA (PROCEDURE).
Who is sponsoring clinical trial NCT02947321?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.